|
Don, don't stretch this out too long! Just remember, this can get a lot worse in the Fall!
|
2
|
Resverlogix Corp.
|
Jun 11, 2020 03:45PM
|
|
Did you notice?
|
4
|
Resverlogix Corp.
|
May 26, 2022 09:59AM
|
|
December 22, 2020.
|
6
|
Resverlogix Corp.
|
Oct 08, 2020 02:10PM
|
|
CTO is here to help move forward COVID-19 studies as quickly as possible.
|
2
|
Resverlogix Corp.
|
Jul 15, 2021 12:36PM
|
|
CTO is here to help move forward COVID-19 studies as quickly as possible.
|
3
|
Resverlogix Corp.
|
Jul 15, 2021 12:41PM
|
|
Covid: Asthma drug 'speeds up recovery at home'
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 11:20PM
|
|
COVID-19 in Alberta: Hospitalizations up 96 per cent over the past 2 weeks .
|
3
|
Resverlogix Corp.
|
Jan 16, 2022 02:32AM
|
|
COVID-19 "competition" to keep an eye on.
|
3
|
Resverlogix Corp.
|
Feb 08, 2021 03:30AM
|
|
Coronavirus Treatment Acceleration Program (CTAP).
|
4
|
Resverlogix Corp.
|
May 19, 2021 05:03PM
|
|
Comment from Mills and Hudson.
|
15
|
Resverlogix Corp.
|
Jan 07, 2021 02:08AM
|
|
Cholesterol may be key to new therapies for Alzheimer's disease, diabetes.
|
7
|
Resverlogix Corp.
|
Apr 19, 2021 01:54PM
|
|
Chew on this one.
|
1
|
Resverlogix Corp.
|
Jun 20, 2020 04:18PM
|
|
Cases of COVID-19 infection are on the rise again in Brazil.
|
1
|
Resverlogix Corp.
|
Jan 05, 2022 02:51AM
|
|
Cancer research derailed by nearly two years due to COVID-19, scientists say.
|
1
|
Zenith Epigenetics
|
Apr 26, 2021 03:41PM
|
|
Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
13
|
Resverlogix Corp.
|
Feb 20, 2022 12:57AM
|
|
BRIEF-Shenzhen Hepalink Pharma Gets Regulatory Approval For Hong Kong IPO.
|
1
|
Resverlogix Corp.
|
Apr 23, 2020 02:16PM
|
|
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
|
6
|
Resverlogix Corp.
|
May 06, 2022 06:19PM
|
|
Before the AGM cut-off.
|
6
|
Resverlogix Corp.
|
Oct 13, 2020 07:09PM
|
|
Bayer and the CKD space we wanted to dominate in.
|
3
|
Resverlogix Corp.
|
Oct 25, 2020 02:17AM
|
|
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach.
|
5
|
Zenith Epigenetics
|
Mar 28, 2020 06:13PM
|
